Nutcracker Therapeutics

Nutcracker’s CSO Samuel Deutsch will be presenting at the Personalized Canver Vaccine Summit in Boston this November!

Are you attending the 2nd Annual Meeting of the Alliance for mRNA Medicines next week? If so, be sure to catch Gad Berdugo's talk on our NMU-Symphony™ platform on September 18 at 1:30 PM PT! Get in contact with our team here: https://lnkd.in/efKCJGAR #mRNATherapeutics #ASCENT2025

Nutcracker’s personalized therapeutic capabilities are highlighted in Nature Biopharma Dealmakers. Looking forward to new era medicines with Samuel Deutsch Benjamin Eldridge

It's nearly here! Babak Sanii will be giving a talk at RNA Leaders on the end-to-end microfluidic manufacturing of personalized cancer therapeutics with our NMU-Symphony™ platform. Attend to learn how we can progress from RNA-design to patient-injectable vials in 3 weeks, and eliminate patient-to-patient risk of cross-contamination with single-use biochips. https://lnkd.in/dhTfJ4VB #mRNATherapeutics #mRNAManufacturing #RNALeaders

Our team had a fantastic time celebrating at our summer social event! As fall approaches, we're wishing everyone a smooth transition and a strong finish to the season.

We'll be in Boston next month to give a presentation at this year's RNA Leaders USA Congress! Two members of our team, Babak Sanii and Gad Berdugo will be attending. We'd love to see you there! Contact our team here:  https://lnkd.in/efKCJGAR

We're excited to be attending the 2nd Annual Meeting of the Alliance for mRNA Medicines Ascent next month! Gad Berdugo will be giving a talk titled: "mRNA Design, Nanoparticle Formulation & Revolutionary GMP, Microfluidic, Biochip-Based, Precision Manufacturing on the NMU-Symphony™ – For Personalized Cancer Therapeutics." We'd love to see you there! Contact our team here: https://lnkd.in/efKCJGAR #mRNATherapeutics #ASCENT2025

RNA-based personalized cancer therapeutics (PCTs) are on track to lead the next wave of transformative RNA therapy approvals. But there’s still no established solution for small-batch, personalized manufacturing. At last month's mRNA-Based Therapeutics Summit, Ole-Audun Haabeth presented on our complete RNA platform for therapeutic design, development and manufacturing – including our CodonCracker™ software for RNA design, Nutshell® delivery vehicles for advanced nanoparticle delivery, and our NMU-Symphony™ for precision RNA manufacturing – particularly PCTs. We had a blast reconnecting with our peers at the summit! Curious about our platform? Dive deeper here: https://lnkd.in/gM2CJ3p

The pandemic showed us that RNA is capable of millions of doses delivered at scale. We believe the next chapter of RNA will focus on something more personal: highly specific RNA therapeutics for smaller patient populations, such as personalized cancer therapeutics. Innovative manufacturing technologies – such as our NMU-Symphony™ platform – are solving longstanding delivery challenges, opening the door to therapies that are not just scalable, but tailored. RNA’s ability to encode virtually any protein gives it the versatility to transform how we think about medicine. Thank you The Medicine Maker for including insights from our CSO, Samuel Deutsch, in Chapter 9 of the Multifaceted Future of Pharma! Learn more here: https://lnkd.in/gb3dktsz #mRNATherapeutics

Today is RNA Day! RNA is a safe and diverse macromolecule – it’s a catalyst, a regulator, a builder, and the backbone of some of the most transformative technologies in medicine and biotech. From personalized cancer therapeutics to CRISPR gene editing, RNA is at the heart of innovation. Fun fact: RNA Day is celebrated on August 1 because of the codon AUG, which signals to start protein synthesis. #RNADay #mRNATherapeutics